课题基金 / 基金详情

A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLE

A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLE
A 期 2、多中心、随机、双盲、安慰剂对照、平行
批准号:
7603684
负责人:
ARSHED A QUYYUMI
金额:
$0.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-09-16

项目摘要

项目成果

ARSHED A QUYYUMI的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary aim of this study is to compare oral 6R-BH4 to placebo with respect to change from baseline in arterial SBP after 8 weeks of treatment in subjects with poorly controlled hypertension. The secondary aim is to compare oral 6R-BH4 to placebo with respect to change from baseline in arterial DBP after 8 weeks of treatment in subjects with poorly controlled hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cardiovascular Disease (CVD) Phenotyping Core
  • 批准号:
    10333815
  • 项目类别:
  • 资助金额:
    $41.13万
  • 财政年份:
    2022
  • 负责人:
    ARSHED A QUYYUMI
  • 依托单位:
Prevalence, Incidence, and Predictors of Subclinical and Clinical Vascular and Myocardial Disease: Pathophysiologic Pathways
  • 批准号:
    10333816
  • 项目类别:
  • 资助金额:
    $11.37万
  • 财政年份:
    2022
  • 负责人:
    ARSHED A QUYYUMI
  • 依托单位:
Prevalence, Incidence, and Predictors of Subclinical and Clinical Vascular and Myocardial Disease: Pathophysiologic Pathways
  • 批准号:
    10622456
  • 项目类别:
  • 资助金额:
    $11.37万
  • 财政年份:
    2022
  • 负责人:
    ARSHED A QUYYUMI
  • 依托单位:
Cardiovascular Project 3
  • 批准号:
    10459330
  • 项目类别:
  • 资助金额:
    $32.36万
  • 财政年份:
    2018
  • 负责人:
    ARSHED A QUYYUMI
  • 依托单位: